Alanine-scanning mutagenesis of WH2 domains of VopF reveals residues important for conferring lethality in a Saccharomyces cerevisiae model

Gene

Volumn 525, Issue 1, 2013, Pages 116-123

  Tripathi, Ranjana ^a   Kaithwas, Vikas ^a   Dureja, Chetna ^a   Raychaudhuri, Saumya ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

Type III effector protein; Vibrio cholerae

Indexed keywords

ALANINE DERIVATIVE; AMINO ACID; BACTERIAL PROTEIN; BACTERIAL PROTEIN VOPF; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; GENETIC CONSERVATION; GENETIC VARIABILITY; GROWTH INHIBITION; HUMAN; LETHALITY; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; VIBRIO CHOLERAE;

ACTINS; ALANINE; AMINO ACID SEQUENCE; AMINO ACIDS; BACTERIAL PROTEINS; FUNGAL PROTEINS; HOMEOSTASIS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE; SEQUENCE ALIGNMENT; VIBRIO CHOLERAE; WISKOTT-ALDRICH SYNDROME PROTEIN;

SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES; VIBRIO CHOLERAE;

EID: 84878892412     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.04.071     Document Type: Article

References (21)

1. Alam A., Miller K.A., Chaand M., Butler J.S., Dziejman M. Identification of V. cholerae type III secretion system effector proteins. Infect. Immun. 2011, 79:1728-1740.
2. Chaudhry F., Little K., Talarico L., Quintero-Monzon Q., Goode B.L. A central role for the WH2 domain of Srv2/CAP in recharging actin monomers to drive actin turnover in vitro and in vivo. Cytoskeleton 2010, 67:120-133.
3. Chereau D., Kerff F., Graceffa P., Grabarek Z., Langsetmo K., Dominguez R. Actin-bound structures of Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 and the applications for filament assembly. Proc. Natl. Acad. Sci. 2005, 102:16644-16649.
4. Collingwood T.N., et al. A natural transactivation mutation in the thyroid hormone β receptor: impaired interaction with putative transcriptional mediators. Proc. Natl. Acad. Sci. 1997, 94:248-253.
5. Didry D., et al. How a singly residue in individual β-thymosin/WH2 domains controls their functions in actin assembly. EMBO J. 2012, 31:1000-1013.
6. Dominguez R. Structural insights into de novo actin polymerization. Curr. Opin. Struct. Biol. 2010, 20:217-225.
7. Dongre M., Khatri N., Dureja C., Raychaudhuri S. Alanine-scanning mutagenesis of selected residues in the N-terminal region alters the functionality of LuxO: lessons from a natural variant LuxOPL91. J. Med. Microbiol. 2011, 60:856-860.
8. Ducka A.M., et al. Structures of actin-bound Wiskott-Aldrich syndrome protein homology 2 (WH2) domains of Spire and the implication for filament nucleation. Proc. Natl. Acad. Sci. 2010, 107:11757-11762.
9. Jewett T.J., Fischer E.R., Mead D.J., Hackstadt T. Chlamydia TARP is a bacterial nucleator of actin. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15599-15604.
10. Lewellyn E.B., Loeb Daniel D. The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication. J. Virol. 2011, 85:1298-1309.
11. Liverman A.D.B., et al. Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17117-17122.
12. Marti{dotless}n H., Rodri{dotless}guez-Pachon J.M., Ruiz C., Nombela C., Molina M. Regulatory mechanisms for modulation of signaling through the cell integrity Slt2-mediated pathway in Saccharomyces cerevisiae. J. Biol. Chem. 2000, 275:1511-1519.
13. Paunola E., Mattila P.K., Lappalainen P. WH2 domain: a small, versatile adapter for actin monomers. FEBS Lett. 2002, 513:92-97.
14. Plamondon P., et al. Phenotypic consequences resulting from a methionine-to-valine substitution at position 48 in the HPr protein of Streptococcus saliverius. J. Bacteriol. 1999, 181:6914-6921.
15. Qualmann B., Kessels M.M. New players in actin polymerization - WH2-domain-containing actin nucleators. Trends Cell Biol. 2009, 19:276-284.
16. Tam V.C., Serruto D., Dziejman M., Brieher W., Mekalanos J.J. A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe 2007, 1:95-107.
17. Tam V.C., et al. Functional analysis of VopF activity required for colonization in Vibrio cholerae. mBio 2010, 1:1-10.
18. Tripathi R., Naorem S.S., Dureja C., Haldar S., Mondal A.K., Raychaudhuri S. VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model. J. Med. Microbiol. 2010, 59:17-24.
19. Van Troys M., Dewitte D., Goethals M., Carlier M.-F., Vandekerckhove J., Ampe C. The actin binding site of thymosin β4 mapped by mutational analysis. EMBO J. 1996, 15:201-210.
20. Vipond I.B., Moon B.-J., Halford S.E. An isoleucine to leucine mutation that switches the cofactor requirement of the EcoRV restriction endoclease from magnesium to manganese. Biochemistry 1996, 35:1712-1721.
21. Yu B., Cheng H.C., Brautigam C.A., Tomchick D.R., Rosen M.K. Mechanism of actin filament nucleation by the bacterial effector VopL. Nat. Struct. Mol. Biol. 2011, 2011(18):1068-1074.